Loading...
Thumbnail Image
Publication

Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed, Uninfected Infants with Prenatal Atazanavir Exposure

Himes, Sarah K.
Huo, Yanling
Siberry, George K.
Williams, Paige L.
Rice, Mabel L.
Sirois, Patricia A.
Frederick, Toni
Hazra, Rohan
Huestis, Marilyn A.
Citations
Altmetric:
Abstract
OBJECTIVE: To investigate whether prenatal atazanavir (ATV) exposure, assessed by meconium antiretroviral quantification, predicts early child language outcomes. Prenatal ATV exposure previously was associated with poorer language development in one-year-olds. METHODS: Pregnant women with HIV and their uninfected infants enrolled in the SMARTT study. Meconium antiretroviral concentrations were quantified by liquid chromatography-tandem mass spectrometry. Language development at 1 year was assessed with MacArthur-Bates Communicative Development Inventory (CDI) and Bayley Scales of Infant and Toddler Development—Third Edition (Bayley-III). Late language emergence (LLE) was defined as ≥ one of four CDI scores ≤10th percentile for age. Associations between fetal ATV exposure timing and duration, meconium ATV concentration, and language outcomes were evaluated, adjusting for potential confounders. RESULTS: Through 2013, meconium samples were available from 175 of 432 infants with prenatal ATV exposure. Valid Bayley-III (n=93) and CDI (n=106) assessments also were available. After adjustment for potential confounders, higher ATV meconium concentrations were associated with lower LLE risk (P=0.04), and cumulative ATV exposure duration also was associated with higher Bayley-III Language scores (P=0.03). Maternal ATV duration and initiation week correlated with ATV meconium concentrations (positively and negatively, respectively). CONCLUSIONS: Higher meconium ATV concentrations were protective against developmental language delays at 1 year, suggesting the importance of fetal ATV detoxification into meconium. This information supports ATV exposure safety for infant language development. ATV is a preferred ARV for pregnant women with HIV, suggesting the importance of ATV safety investigations. Additionally, further pursuit of the influences on language development in HEU infants is required.
Description
This is not the published version.
Date
2015-06-01
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott, Williams & Wilkins
Research Projects
Organizational Units
Journal Issue
Keywords
Econium, Atazanavir, Antiretroviral, language, HIV-exposed infants
Citation
Himes, S. K., Huo, Y., Siberry, G. K., Williams, P. L., Rice, M. L., Sirois, P. A., … Huestis, M. A. (2015). Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed, Uninfected Infants with Prenatal Atazanavir Exposure. Journal of Acquired Immune Deficiency Syndromes (1999), 69(2), 178–186. http://doi.org/10.1097/QAI.0000000000000558
Embedded videos